Other positive effects of TNF-α and IL-1β release stems from the fact that prior work from our laboratory demonstrated that both cytokines are necessary to restore the mixed lymphocyte reaction ability of DCs after phagocytosis of tumor irradiated cells (47). The gene discussed is IL1B; the disease is neoplasm.